Reforming China's drug regulatory system

被引：0
|
作者：
Lili Xu
Huijun Gao
Kenneth I. Kaitin
Liming Shao
机构：
[1] Fudan Center for Study of Pharmaceuticals and Healthcare Strategy,
[2] Shanghai Association of Food and Drug Safety,undefined
[3] Tufts Center for the Study of Drug Development,undefined
[4] Tufts University School of Medicine,undefined
来源：
Nature Reviews Drug Discovery | 2018年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Since 2015, the Chinese government has introduced numerous reforms with the aim of establishing a more scientific and efficient drug regulatory system, which are highlighted here.
引用
收藏
页码：858 / 859
页数：1
相关论文
共 50 条
  • [41] Reforming China's banking system: How much can foreign strategic investment help?
    Hope, Nicholas
    Hu, Fred
    China and India: Learning From Each Other - Reforms and Policies for Sustained Growth, 2006, : 33 - 83
  • [42] Reforming the world's largest heating system: Quasi-experimental evidence from China
    Wang, Manyu
    Huang, Ying
    An, Zidong
    Wei, Chu
    ENERGY ECONOMICS, 2023, 117
  • [43] Incorporating VOC Emission Control in China’s Hazardous Waste Regulatory System
    Yan, Gang
    Zheng, Yixuan
    Tang, Qian
    Ning, Miao
    Lei, Yu
    Environmental Science and Technology, 2021, 55 (23): : 15569 - 15571
  • [44] Incorporating VOC Emission Control in China's Hazardous Waste Regulatory System
    Yan, Gang
    Zheng, Yixuan
    Tang, Qian
    Ning, Miao
    Lei, Yu
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2021, 55 (23) : 15569 - 15571
  • [45] The development of China's vaccine industry in the past decade: the perspective from drug regulatory science
    Wang, Guanjie
    Shao, Mingli
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (12) : 5666 - 5672
  • [46] Challenges in orphan drug development and regulatory policy in China
    Cheng, Alice
    Xie, Zhi
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12 : 1 - 8
  • [47] Recent Advances in Drug Development and Regulatory Science in China
    Jie Chen
    Naiqing Zhao
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 739 - 750
  • [48] Recent Advances in Drug Development and Regulatory Science in China
    Chen, Jie
    Zhao, Naiqing
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (06) : 739 - 750
  • [49] Challenges in orphan drug development and regulatory policy in China
    Alice Cheng
    Zhi Xie
    Orphanet Journal of Rare Diseases, 12
  • [50] Reforming China's State-owned Enterprises
    Kratz, Agatha
    CHINA PERSPECTIVES, 2013, 1 : 94 - 96
12345